NCT07807436

Brief Summary

This study compared a modified soft contact lens with balanced salt solution irrigation during pars plana vitrectomy performed with a noncontact wide-angle viewing system. Participants requiring vitrectomy were randomly assigned to have the modified lens placed on the cornea throughout surgery or to receive intermittent balanced salt solution irrigation. The study evaluated whether the modified lens could maintain a clear surgical view and protect the corneal surface. Participants were followed for one month after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2023

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

September 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 8, 2026

Completed
Last Updated

September 8, 2026

Status Verified

August 1, 2026

Enrollment Period

8 months

First QC Date

September 1, 2026

Last Update Submit

September 1, 2026

Conditions

Keywords

VitrectomyBandage Soft Contact LensCorneal ProtectionNoncontact Wide-Angle Viewing System

Outcome Measures

Primary Outcomes (1)

  • Intraoperative Clarity of the Surgical Field

    Surgical-field clarity was graded on a 4-point ordinal scale: 1, poor visibility requiring corneal epithelial scraping; 2, slightly unclear but permitting basic identification of retinal vessels and the optic disc; 3, clear enough for epiretinal membrane peeling; and 4, excellent visibility permitting delicate macular procedures.

    During pars plana vitrectomy

Secondary Outcomes (8)

  • Frequency of Corneal Irrigation

    During pars plana vitrectomy

  • Total Operative Time

    During surgery

  • Vitrectomy Duration

    During surgery

  • Corneal Edema Grade

    Preoperatively and at 1 day, 1 week, and 1 month after surgery

  • Corneal Epithelial Fluorescein Staining Score

    Preoperatively and at 1 day, 1 week, and 1 month after surgery

  • +3 more secondary outcomes

Study Arms (2)

Modified Soft Contact Lens

EXPERIMENTAL

A modified 10.5-mm silicone hydrogel soft contact lens was placed on the corneal surface after surgical draping and maintained throughout pars plana vitrectomy.

Device: Modified Soft Contact Lens

Balanced Salt Solution Irrigation

ACTIVE COMPARATOR

Balanced salt solution was applied intermittently to the corneal surface as required to maintain corneal hydration and clarity during pars plana vitrectomy.

Other: Balanced Salt Solution Irrigation

Interventions

Balanced salt solution was applied intermittently to the corneal surface as required during pars plana vitrectomy to maintain corneal hydration and surgical-field clarity.

Balanced Salt Solution Irrigation

A 10.5-mm silicone hydrogel corneal bandage soft contact lens was placed on the corneal surface immediately after surgical draping and maintained throughout pars plana vitrectomy.

Modified Soft Contact Lens

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of a retinal disease requiring pars plana vitrectomy.
  • Corneal endothelial cell density of at least 2,000 cells/mm².
  • No ocular surface disease or significant anterior-segment abnormality.
  • No ocular surgery or trauma within the previous month, except intravitreal anti-VEGF injection.
  • Considered suitable for ophthalmic surgery under routine clinical conditions.

You may not qualify if:

  • Refusal to participate or withdrawal from the study.
  • Syncope or inability to tolerate study examinations or surgery.
  • Incomplete study data.
  • Any condition judged by the investigator to interfere with corneal assessment, including corneal edema secondary to persistently elevated intraocular pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xi'an First Hospital

Xi'an, Shaanxi, 710002, China

Location

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Chief Physician

Study Record Dates

First Submitted

September 1, 2026

First Posted

September 8, 2026

Study Start

April 25, 2022

Primary Completion

December 30, 2022

Study Completion

January 30, 2023

Last Updated

September 8, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations